ANAPTYSBIO, INC. Increase (Decrease) in Contract with Customer, Asset
ANAPTYSBIO, INC. (ANAB) reported Increase (Decrease) in Contract with Customer, Asset of -$8.22 million for the 6-month period ending 2026-06-30, per its 10-KT filed 2026-09-21.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2026-09-21
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for the quarter ending 2026-06-30 was -$113.00K, a 100.27% decline year-over-year.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for the quarter ending 2026-03-31 was -$8.10M.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for the quarter ending 2025-12-31 was -$41.84M, a 246.43% decline year-over-year.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for the quarter ending 2025-09-30 was $15.57M, a 388.49% increase year-over-year.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for fiscal 2025 was -$6.92M, a 120.39% decline from fiscal 2024.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for fiscal 2024 was $33.91M, a 524.34% increase from fiscal 2023.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for fiscal 2023 was $5.43M, a 900.37% increase from fiscal 2022.
- ANAPTYSBIO, INC. increase (decrease) in contract with customer, asset for fiscal 2022 was $543.00K, a 38.01% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 6 month as first filed | Increase (Decrease) in Contract with Customer, Asset 9 month | Increase (Decrease) in Contract with Customer, Asset 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$113.00K derived: 10-KT 6 month − 10-Q 3 month · filed 2026-09-21 | -$8.22M 10-KT · filed 2026-09-21 | -$50.05M derived: sum of 3 quarters · filed 2026-09-21 | -$34.48M derived: sum of 4 quarters · filed 2026-09-21 | |
| 2026-03-31 | -$8.10M 10-Q · filed 2026-05-12 | -$49.94M derived: sum of 2 quarters · filed 2026-09-21 | -$34.37M derived: sum of 3 quarters · filed 2026-09-21 | $7.86M derived: sum of 4 quarters · filed 2026-09-21 | |
| 2025-12-31 | -$41.84M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | -$26.26M derived: sum of 2 quarters · filed 2026-09-21 | $15.97M derived: sum of 3 quarters · filed 2026-09-21 | -$6.92M 10-KT · filed 2026-09-21 | |
| 2025-09-30 | $15.57M derived: 10-Q 9 month − 10-KT 6 month · filed 2025-11-04 | $57.80M derived: sum of 2 quarters · filed 2026-09-21 | $34.92M 10-Q · filed 2025-11-04 | $63.49M derived: sum of 4 quarters · filed 2026-09-21 | |
| 2025-06-30 | $42.23M derived: 10-KT 6 month − 10-Q 3 month · filed 2026-09-21 | $19.35M 10-KT · filed 2026-09-21 | -$19.35M 10-Q · filed 2025-08-06 | $47.92M derived: sum of 3 quarters · filed 2026-09-21 | $51.10M derived: sum of 4 quarters · filed 2026-09-21 |
| 2025-03-31 | -$22.88M 10-Q · filed 2026-05-12 | $5.69M derived: sum of 2 quarters · filed 2026-09-21 | $8.88M derived: sum of 3 quarters · filed 2026-09-21 | $10.79M derived: sum of 4 quarters · filed 2026-09-21 | |
| 2024-12-31 | $28.57M derived: 10-KT 12 month − 10-Q 9 month · filed 2026-09-21 | $31.76M derived: sum of 2 quarters · filed 2026-09-21 | $33.68M derived: sum of 3 quarters · filed 2026-09-21 | $33.91M 10-KT · filed 2026-09-21 | |
| 2024-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.11M derived: sum of 2 quarters · filed 2025-11-04 | $5.34M 10-Q · filed 2025-11-04 | $8.93M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.16M 10-Q · filed 2025-08-06 | $5.74M derived: sum of 3 quarters · filed 2026-03-03 | $5.83M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-03-31 | $238.00K 10-Q · filed 2025-05-05 | $3.82M derived: sum of 2 quarters · filed 2026-03-03 | $3.91M derived: sum of 3 quarters · filed 2026-03-03 | $5.57M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2023-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.67M derived: sum of 2 quarters · filed 2026-03-03 | $5.33M derived: sum of 3 quarters · filed 2026-03-03 | $5.43M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.75M derived: sum of 2 quarters · filed 2024-11-05 | $1.85M 10-Q · filed 2024-11-05 | $2.09M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.76M 10-Q · filed 2024-08-05 | $2.00M derived: sum of 3 quarters · filed 2025-02-27 | $2.15M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $104.00K 10-Q · filed 2024-05-09 | $343.00K derived: sum of 2 quarters · filed 2025-02-27 | $490.00K derived: sum of 3 quarters · filed 2025-02-27 | $602.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $386.00K derived: sum of 2 quarters · filed 2025-02-27 | $498.00K derived: sum of 3 quarters · filed 2025-02-27 | $543.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $259.00K derived: sum of 2 quarters · filed 2023-11-02 | $304.00K 10-Q · filed 2023-11-02 | $419.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $157.00K 10-Q · filed 2023-08-07 | $272.00K derived: sum of 3 quarters · filed 2024-03-11 | $391.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2022-03-31 | $45.00K 10-Q · filed 2023-05-11 | $160.00K derived: sum of 2 quarters · filed 2024-03-11 | $279.00K derived: sum of 3 quarters · filed 2024-03-11 | -$326.00K derived: sum of 4 quarters · filed 2024-03-11 | |
| 2021-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $234.00K derived: sum of 2 quarters · filed 2024-03-11 | -$371.00K derived: sum of 3 quarters · filed 2024-03-11 | $876.00K 10-K · filed 2024-03-11 | |
| 2021-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$486.00K derived: sum of 2 quarters · filed 2022-11-08 | $761.00K 10-Q · filed 2022-11-08 | $761.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $642.00K 10-Q · filed 2022-08-08 | $642.00K derived: sum of 3 quarters · filed 2023-03-01 | $642.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-04 | $1.25M derived: sum of 2 quarters · filed 2023-03-01 | $1.25M derived: sum of 3 quarters · filed 2023-03-01 | -$3.75M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | -$5.00M derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$5.00M derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2022-03-07 | |
| 2020-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-03-07 | -$5.00M derived: sum of 4 quarters · filed 2022-03-07 | |
| 2020-03-31 | $5.00M 10-Q · filed 2021-05-04 | $5.00M derived: sum of 2 quarters · filed 2022-03-07 | $0.00 derived: sum of 3 quarters · filed 2022-03-07 | $5.00M derived: sum of 4 quarters · filed 2022-03-07 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$5.00M derived: sum of 2 quarters · filed 2022-03-07 | $0.00 derived: sum of 3 quarters · filed 2022-03-07 | $0.00 10-K · filed 2022-03-07 | |
| 2019-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2020-08-10 | $0.00 10-Q · filed 2019-11-08 | -$5.00M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $5.00M 10-Q · filed 2020-08-10 | $0.00 derived: sum of 3 quarters · filed 2020-08-10 | $5.00M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | -$5.00M derived: sum of 2 quarters · filed 2020-05-06 | $0.00 derived: sum of 3 quarters · filed 2020-05-06 | ||
| 2018-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | ||
| 2018-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $5.00M 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | -$1.23M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.23M 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | -$1.23M 10-Q · filed 2018-08-07 | ||||
| 2016-12-31 | -$1.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |